Quadrant Capital Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-347
| Closed | -$4.37K | – | 2450 |
|
|
2025
Q1 | $4.37K | Hold |
347
| – | – | ﹤0.01% | 2380 |
|
|
2024
Q4 | $3.66K | Hold |
347
| – | – | ﹤0.01% | 2379 |
|
|
2024
Q3 | $5.03K | Hold |
347
| – | – | ﹤0.01% | 2318 |
|
|
2024
Q2 | $2.95K | Hold |
347
| – | – | ﹤0.01% | 2415 |
|
|
2024
Q1 | $3.55K | Hold |
347
| – | – | ﹤0.01% | 2397 |
|
|
2023
Q4 | $1.9K | Buy |
+347
| New | +$1.9K | ﹤0.01% | 2483 |
|